Patent · US Active

Caspase inhibitors and methods of use thereof

US11597703B2 · kind B2 · utility

0Cited by

53References

21Claims

0Family size

Assignee

Histogen, Inc. · US

Inventors

Alfred P. Spada · Lansdale, US
Robert J. Temansky · San Diego, US
Michael Mueller · Gifhorn, DE

Key dates

Filing date	Mar 6, 2020
Grant date	Mar 7, 2023
Priority date	—
Expiry date	Mar 6, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D333/16
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Provided herein are compounds of formula I, compositions comprising the compounds and method of treating various diseases with the compounds and compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.